69 Pharma Startups to Watch (and Work for) in 2023
The Pharma tech sector in Europe booming. In 2022, Pharma raised $1.9 Billion in capital (after raising $2.2 Billion in 2021). Whether you're an experienced investor, a determined founder, or a resourceful operator this year's list of top 69 tech startups is worth exploring. It includes companies of various sizes, ranging from those experiencing rapid growth to smaller, creative startups.
Last update: September 12, 2023
Featured companies in Pharma
Get access to the Seedtable database with +15,000 companies (266 from Pharma)Featured
Biomedical research discovery tool.
-
Latest Funding
$60 Million · Series B
-
Employees
51 to 100
-
Investors
Marathon VC, Pentech Ventures, ICONIQ Growth, Index Ventures
-
Business Model
B2B, SAAS
-
Industries
Health Tech, AI, Biotech, Pharma
-
Locations
London
-
Contact
•••••@causaly.com
Unlock contact info
Featured
Producer of gut health binding proteins.
-
Latest Funding
$33 Million · Series A
-
Employees
1 to 10
-
Investors
Bill & Melinda Gates Foundation, Novo A/S
-
Business Model
B2B
-
Industries
Biotech, Pharma
-
Locations
Copenhagen
-
Contact
•••••@bactolife.com
Unlock contact info
Featured
Treatments for genetic bleeding disorders.
-
Latest Funding
$140 Million · Series B
-
Employees
1 to 10
-
Investors
HealthCap, Novo A/S
-
Business Model
B2B
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
Copenhagen
-
Contact
•••••@hemab.com
Unlock contact info
List of 69 top tech companies in Pharma
Get access to the Seedtable database with +15k companies (266 from Pharma)Cancer treatment predictor software.
-
Latest Funding
$14 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Hoxton Ventures, Octopus Ventures, Fly Ventures
-
Contact
•••••@pearbio.com
Unlock contact info
ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
-
Latest Funding
$44 Million · Series C
-
Industries
Health Tech, Biotech, Pharma
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Andera Partners, Novo A/S
-
Contact
•••••@reviral.co.uk
Unlock contact info
SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications.
-
Latest Funding
$48 Million
-
Industries
Health Tech, Hardware, Pharma, Manufacturing
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Sofinnova Partners
-
Contact
•••••@safeheal.com
Unlock contact info
Cloud-based clinical data platform.
-
Latest Funding
$45 Million · Series B
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Amsterdam
-
Employees
101 to 250
-
Business Model
B2B, SAAS
-
Investors
Eight Roads Ventures, Inkef Capital
-
Contact
•••••@castoredc.com
Unlock contact info
Immuno-oncology company treats cancer with antibodies.
-
Latest Funding
$42 Million
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Epidarex Capital, AlbionVC, Novartis Venture Fund
-
Contact
•••••@epsilogen.com
Unlock contact info
Data capture for clinical trials.
-
Latest Funding
$2.4 Million · Seed
-
Industries
Health Tech, Pharma, Data and Analytics
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Bpifrance
-
Contact
•••••@kayentis.com
Unlock contact info
Manual provides diagnostic tools and testing to help patients make health-related decisions.
-
Latest Funding
$30 Million · Series A
-
Industries
Health Tech, Fashion, Pharma, Mobile, Ecommerce
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2C
-
Investors
Felix Capital, Cherry Ventures, FJ Labs
-
Contact
•••••@manual.co
Unlock contact info
Manufacturer of radio-immunotherapeutic drugs for cancer patients.
-
Latest Funding
$88 Million · Series B
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing
-
Locations
Brussels
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Gimv, Forbion Capital Partners, BioMedPartners, HealthCap, V-Bio Ventures, Novo A/S, Inkef Capital
-
Contact
•••••@precirix.com
Unlock contact info
Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).
-
Latest Funding
$41 Million · Series B
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
AGORANOV, Bpifrance, Idinvest Partners, Hadean Ventures
-
Contact
•••••@step-ph.com
Unlock contact info
AI drug discovery platform.
-
Latest Funding
$16 Million · Series A
-
Industries
Pharma
-
Locations
Paris
-
Employees
11 to 50
-
Investors
M Ventures
-
Contact
•••••@iktos.ai
Unlock contact info
Diagnosis and treatment of hard-to-treat cancers.
-
Latest Funding
$25 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Berlin
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Andera Partners, HealthCap, Pureos Bioventures, Earlybird Venture Capital
-
Contact
•••••@ariceum-therapeutics.com
Unlock contact info
Clinical-stage central nervous system (CNS) technology.
-
Latest Funding
$110 Million · Series B
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Basel
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Forbion Capital Partners, BioMedPartners, Sofinnova Partners
-
Contact
•••••@noemapharma.com
Unlock contact info
Qualifyze making supply chains in life sciences more transparent and secure at affordable costs.
-
Latest Funding
$12 Million · Series A
-
Industries
AI, Pharma, Business Intelligence
-
Locations
Frankfurt
-
Employees
11 to 50
-
Business Model
B2B, MARKETPLACE
-
Investors
H14, HV Capital, Cherry Ventures, Coparion, APX
-
Contact
•••••@qualifyze.com
Unlock contact info
Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.
-
Latest Funding
$43 Million · Series F
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
Paris
-
Employees
51 to 100
-
Business Model
B2B
-
Investors
Omnes Capital, Nestlé Health Science, Seventure Partners
-
Contact
•••••@enterome.com
Unlock contact info
Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.
-
Latest Funding
$6 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Fountain Healthcare Partners
-
Contact
•••••@ermium.com
Unlock contact info
Developer of therapies for treating chronic inflammatory conditions.
-
Latest Funding
$21 Million · Series C
-
Industries
Health Tech, Pharma
-
Locations
Stockholm
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Hadean Ventures, Industrifonden
-
Contact
•••••@gesynta.se
Unlock contact info
HMNC Brain Health is a precision medicine pioneer in psychiatry based in Munich.
-
Latest Funding
$14 Million
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing
-
Locations
Munich
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
ALSTIN Capital
-
Contact
•••••@hmnc-brainhealth.com
Unlock contact info
Lyphe group is a reliable supplier of medical cannabis care and medicine.
-
Latest Funding
$6.2 Million · Series A
-
Industries
Health Tech, Agritech, Pharma, Manufacturing, Cannabis
-
Locations
London
-
Employees
51 to 100
-
Business Model
B2B
-
Investors
Leafy Tunnel
-
Contact
•••••@lyphegroup.com
Unlock contact info
Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors.
-
Latest Funding
$6 Million · Seed
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Sofinnova Partners
-
Contact
•••••@myricxpharma.com
Unlock contact info
We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.
-
Latest Funding
$40 Million · Series A
-
Industries
Health Tech, Biotech, Pharma, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Hoxton Ventures, Bessemer Venture Partners
-
Contact
•••••@peptone.io
Unlock contact info
Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.
-
Latest Funding
$17 Million · Seed
-
Industries
Health Tech, Biotech, Pharma, Manufacturing
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
XAnge, Quantonation
-
Contact
•••••@qubit-pharmaceuticals.com
Unlock contact info
Testing and certifications platform for any material, product or chemical.
-
Latest Funding
$2.7 Million · Seed
-
Industries
Biotech, Pharma
-
Locations
Helsinki
-
Employees
11 to 50
-
Investors
VentureFriends, Lifeline Ventures
-
Contact
•••••@measurlabs.com
Unlock contact info
Gene therapy research to tackle genetic diseases.
-
Latest Funding
$60 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Zürich
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Gimv
-
Contact
•••••@anjarium.com
Unlock contact info
Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.
-
Latest Funding
$76 Million
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Hanover
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
BioMedPartners, Inkef Capital, Hadean Ventures, Coparion, High-Tech Gründerfonds
-
Contact
•••••@cardior.de
Unlock contact info
Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
-
Latest Funding
$99 Million
-
Industries
Health Tech, Biotech, Pharma, Fitness, Manufacturing
-
Locations
Duisburg
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Hadean Ventures, High-Tech Gründerfonds
-
Contact
•••••@emergencetx.com
Unlock contact info
F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.
-
Latest Funding
$70 Million
-
Industries
Health Tech, Biotech, Pharma, Genetics
-
Locations
Manchester
-
Employees
251 to 500
-
Business Model
B2B
-
Investors
Forbion Capital Partners, Sofinnova Partners, Novo A/S
-
Contact
•••••@f2g.com
Unlock contact info
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
-
Latest Funding
$56 Million · Series B
-
Industries
Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence
-
Locations
Cambridge
-
Employees
51 to 100
-
Business Model
B2B, SAAS
-
Investors
Balderton Capital, Amadeus Capital, Atomico, btov Partners
-
Contact
•••••@healx.io
Unlock contact info
ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.
-
Latest Funding
$100 Million
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
Marseille
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Gimv, Eurazeo, Andera Partners, Earlybird Venture Capital
-
Contact
•••••@imchecktherapeutics.com
Unlock contact info
ImmunOs Therapeutics is a clinical-stage biotechnology company.
-
Latest Funding
$74 Million
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Zürich
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Gimv, BioMedPartners, Lightspeed Venture Partners
-
Contact
•••••@immunostherapeutics.com
Unlock contact info
Lab-quality diagnostics for anyone, anywhere, at any time.
-
Latest Funding
$85 Million · Series C
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
Oxford
-
Employees
51 to 100
-
Business Model
B2B
-
Investors
Oxford Science Enterprises
-
Contact
•••••@oslerdiagnostics.com
Unlock contact info
Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.
-
Latest Funding
$280 Million
-
Industries
Health Tech, Biotech, Pharma, Robotics, Manufacturing, Genetics
-
Locations
Oxford
-
Employees
251 to 500
-
Business Model
B2B
-
Investors
Wellington Management
-
Contact
•••••@nanoporetech.com
Unlock contact info
SkyCell developed the next generation of temperature controlled logistics containers for the pharmaceutical industry.
-
Industries
AI, Pharma, Mobility & Transportation
-
Locations
Zürich
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
MVM Life Science Partners
-
Contact
•••••@skycell.ch
Unlock contact info
Medical device company developing a closure device for vascular access procedures.
-
Latest Funding
$32 Million · Series D
-
Industries
Health Tech, Hardware, Biotech, Pharma, Manufacturing
-
Locations
Galway
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Fountain Healthcare Partners
-
Contact
•••••@vivasuremedical.com
Unlock contact info
Drug discovery - Pharma 3.0
-
Latest Funding
$29 Million · Series A
-
Industries
Health Tech, AI, Biotech, Machine Learning, Pharma, Quantum Computing
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Eurazeo, Elaia
-
Contact
•••••@aqemia.com
Unlock contact info
CimCure focuses on design and development of a novel class of active cancer immunotherapies.
-
Latest Funding
$5.4 Million · Seed
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Amsterdam
- Employees
-
Business Model
B2B
-
Investors
Positron Ventures
-
Contact
•••••@cimcure.com
Unlock contact info
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
-
Latest Funding
$11 Million · Series A
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Thia Ventures, XAnge, Entrepreneur First, Plug and Play Spain
-
Contact
•••••@corebiogenesis.com
Unlock contact info
AI-powered data collecting tool for clinical trials.
-
Latest Funding
$20 Million · Series A
-
Industries
Health Tech, AI, Biotech, Machine Learning, Pharma
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Cathay Innovation, Serena, Fly Ventures, Kima Ventures
-
Contact
•••••@inato.com
Unlock contact info
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
-
Latest Funding
$73 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Copenhagen
- Employees
-
Business Model
B2B
-
Investors
Sofinnova Partners, V-Bio Ventures, Novo A/S, VIB
-
Contact
•••••@munatherapeutics.com
Unlock contact info
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.
-
Latest Funding
$68 Million · Series A
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Forbion Capital Partners
-
Contact
•••••@pheontx.com
Unlock contact info
Developer of innovative treatment for muscle wasting disorders.
-
Latest Funding
$6.1 Million · Series A
-
Industries
Biotech, Pharma
-
Locations
London
-
Employees
1 to 10
-
Investors
Mankind Pharma
-
Contact
•••••@actimedtherapeutics.com
Unlock contact info
Immunotherapy for the treatment of cancer.
-
Latest Funding
$1.5 Million · Seed
-
Industries
Biotech, Pharma
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2C
-
Investors
Cancer Research Horizons, UK Innovation & Science Seed Fund
-
Contact
•••••@nk-io.com
Unlock contact info
Novel antiobiotic researcher to fight antimicrobial resistance.
-
Latest Funding
$9 Million · Series C
-
Industries
Biotech, Pharma
-
Locations
Basel
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
AMR Action Fund
-
Contact
•••••@bioversys.com
Unlock contact info
Cinclus Pharma is a research based biotech company.
-
Latest Funding
$26 Million
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Gothenburg
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
EIR Ventures
-
Contact
•••••@cincluspharma.com
Unlock contact info
Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
-
Latest Funding
$44 Million
-
Industries
Health Tech, Biotech, Pharma, Manufacturing, Genetics
-
Locations
Oxford
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Oxford Science Enterprises
-
Contact
•••••@nucleome.com
Unlock contact info
AFYX Therapeutics is a clinical stage biopharmaceutical company
-
Latest Funding
$13 Million
-
Industries
Health Tech, Edtech, Biotech, Pharma, Food Delivery
-
Locations
Copenhagen
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Sofinnova Partners
-
Contact
•••••@afyxtx.com
Unlock contact info
Therapeutics treatment for strokes and brain injury.
-
Latest Funding
$2.7 Million
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Madrid
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Caixa Capital Risc, Inveready
-
Contact
•••••@aptatargets.com
Unlock contact info
Baseimmune is a biotech startup founded to create the next generation of vaccines.
-
Latest Funding
$4.8 Million · Seed
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Hoxton Ventures, Cherry Ventures, Creator Fund, Maki.vc
-
Contact
•••••@baseimmune.co.uk
Unlock contact info
Biosyntia is a biotech startup within synthetic biology and metabolic engineering.
-
Latest Funding
$12 Million · Series B
-
Industries
Health Tech, Biotech, Pharma, Manufacturing
-
Locations
Copenhagen
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Sofinnova Partners
-
Contact
•••••@biosyntia.com
Unlock contact info
Casein protein manufacturer for animal-free cheese.
-
Latest Funding
$5 Million · Seed
-
Industries
Foodtech, Biotech, Pharma, Manufacturing
-
Locations
Vienna
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Climentum Capital, PUSH Ventures, BackBone Ventures
-
Contact
•••••@fermify.org
Unlock contact info
Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer.
-
Latest Funding
$34 Million · Series A
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
Barcelona
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Ysios Capital, Asabys Partners
-
Contact
•••••@ona-therapeutics.com
Unlock contact info
Rappta Therapeutics is a lead-optimization stage biopharmaceutical company.
-
Latest Funding
$11 Million · Series A
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
Helsinki
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Novartis Venture Fund, Novo A/S
-
Contact
•••••@rappta-therapeutics.com
Unlock contact info
Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated.
-
Latest Funding
$35 Million · Series C
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Internet of Things
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Sofinnova Partners
-
Contact
•••••@synthace.com
Unlock contact info
Portfolio of pharmaceutical research and discovery.
-
Latest Funding
$230 Million · Series C
-
Industries
Biotech, Pharma
-
Locations
London
-
Employees
1 to 10
-
Investors
Patient Square Capital, Rock Springs Capital
-
Contact
•••••@apollotherapeutics.com
Unlock contact info
Abalos Therapeutics is an Essen, Germany-based developer of novel immuno-virotherapies against cancer.
-
Latest Funding
$50 Million
-
Industries
Health Tech, Biotech, Pharma, Manufacturing
-
Locations
Essen
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Seventure Partners, Coparion, High-Tech Gründerfonds
-
Contact
•••••@abalos-tx.com
Unlock contact info
AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
-
Latest Funding
$30 Million · Seed
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Leuven
- Employees
-
Business Model
B2B
-
Investors
V-Bio Ventures
-
Contact
•••••@astrivax.com
Unlock contact info
Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.
-
Latest Funding
$33 Million
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Aarhus
-
Employees
10001+
-
Business Model
B2B
-
Investors
Inkef Capital, High-Tech Gründerfonds
-
Contact
•••••@draupnir.bio
Unlock contact info
GlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics.
-
Latest Funding
$49 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Zürich
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Sofinnova Partners
-
Contact
•••••@glycoera.com
Unlock contact info
Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases
-
Latest Funding
$20 Million · Series B
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing
-
Locations
Turin
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Claris Ventures, CDP Venture Capital Sgr
-
Contact
•••••@kitherbiotech.com
Unlock contact info
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
-
Latest Funding
$40 Million
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Aarhus
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Novo A/S, Inkef Capital
-
Contact
•••••@nmdpharma.com
Unlock contact info
Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
-
Latest Funding
$23 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Trento
- Employees
-
Business Model
B2B
-
Investors
V-Bio Ventures, Seroba Life Sciences, Claris Ventures, CDP Venture Capital Sgr
-
Contact
•••••@sibyllabiotech.it
Unlock contact info
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
-
Latest Funding
$22 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Aarhus
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Novo A/S, Wellington Partners
-
Contact
•••••@stipetherapeutics.com
Unlock contact info
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.
-
Latest Funding
$44 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Utrecht
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Andera Partners, Inkef Capital, Hadean Ventures
-
Contact
•••••@targedbiopharmaceuticals.com
Unlock contact info
TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.
-
Latest Funding
$75 Million
-
Industries
Health Tech, Biotech, Pharma, Manufacturing
-
Locations
Bordeaux
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
XAnge
-
Contact
•••••@treefrog.fr
Unlock contact info
ViCentra has developed an insulin pump for diabetes patients.
-
Latest Funding
$73 Million
-
Industries
Health Tech, Hardware, Pharma
-
Locations
Utrecht
-
Employees
11 to 50
-
Business Model
B2C
-
Investors
Kreos Capital, Invest-NL, Inkef Capital
-
Contact
•••••@hellokaleido.com
Unlock contact info
Patent-protected anti-inflammatory painkiller.
-
Latest Funding
$6.3 Million · Series A
-
Industries
Biotech, Pharma
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2C
-
Investors
ITV AdVentures
-
Contact
•••••@flarin.co.uk
Unlock contact info
Online Pharmacy and Integrated Healthcare Platform
-
Latest Funding
$15 Million · Series A
-
Industries
Health Tech, Pharma, Sales and Marketing, Ecommerce
-
Locations
Milan
-
Employees
11 to 50
-
Business Model
B2B, B2C, MARKETPLACE, SAAS
-
Investors
P101, LIFTT, HBM Partners, Healthware Ventures
-
Contact
•••••@1000farmacie.it
Unlock contact info